Opioid Manufacturer Pays $225M for Doctor Bribery Scheme
Insys Therapeutics, an opioid manufacturer, has agreed to pay $225 million to settle the federal government's criminal and civil investigations into the company's marketing practices involving opioids. The Company admitted to nationwide scheme of bribing doctors to prescribe its fentanyl-based medication, Subsys as a painkiller to patients, who didn't need it, as part of its "speaker program." This settlement follows a jury last month finding five top Insys Therapeutics executives guilty of racketeering conspiracy for these same practices. Click here to read more about the Insys case.